SAN JOSE, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — Rani Therapeutics (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the oral delivery of biologics, today announced that the company’s Chief Executive Officer, Talat Imran, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference on Thursday, September 30, 2021, at 9:00 a.m. PT / 12:00 p.m. ET.
Interested parties can access the live audio webcast for this conference from the Events page in the Investor Relations section of the company’s website at www.ranitherapeutics.com. The webcast replay will be available after the conclusion of the live presentation for approximately 30 days.
About Rani Therapeutics
Rani Therapeutics is a clinical stage biotherapeutics company focused on the oral delivery of biologics, which we believe will have the potential to transform medicine and improve patient outcomes. The company has developed the RaniPill™ capsule, a novel, proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability and bioavailability using the RaniPill™ capsule.
Investor Contact:
investors@ranitherapeutics.com
Media Contact:
media@ranitherapeutics.com
Source: Rani Therapeutics
Vancouver, British Columbia--(Newsfile Corp. - March 28, 2024) - CENTR Brands Corp. (CSE: CNTR) (FSE:…
BOCA RATON, FL / ACCESSWIRE / March 28, 2024 / Haven Health Care Services, a…
BOULDER, CO / ACCESSWIRE / March 28, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global…
JACKSONVILLE, FL / ACCESSWIRE / March 28, 2024 / LFTD Partners Inc. ("LFTD Partners" or…
Unify Medical, Inc., a privately held, smart surgical visualization technology company, announced the appointment of…
Texas-based specialty practice chooses eClinicalWorks Cloud EHR to increase automation, streamline workflows, and enhance patient…